US9962359 — Methods of therapeutic monitoring of nitrogen scavenging drugs
Method of Use · Assigned to Horizon Therapeutics LLC · Expires 2030-09-22 · 4y remaining
What this patent protects
This patent protects methods for evaluating daily ammonia exposure and adjusting the dosage of a nitrogen scavenging drug, such as Ravicti.
USPTO Abstract
The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods that utilize this technique to adjust the dosage of a nitrogen scavenging drug, determine whether to administer a nitrogen scavenging drug, and treat nitrogen retention disorders.
Drugs covered by this patent
- Ravicti (GLYCEROL PHENYLBUTYRATE) · Horizon Therap Us
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1816 |
— | Ravicti |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.